|
2CLW
Crystal structure of human ubiquitin-conjugating enzyme UbcH5B
Deposited 2006-05-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
SO4 SULFATE ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;150 MM AMMONIUM SULPHATE, 100 MM SODIUM ACETATE TRIHYDRATE [PH 4.6], 25% W/V PEG MME 2000
|
Resolution 1.95 Å
R-free 0.255
|
|
2CLW
Crystal structure of human ubiquitin-conjugating enzyme UbcH5B
Deposited 2006-05-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;150 MM AMMONIUM SULPHATE, 100 MM SODIUM ACETATE TRIHYDRATE [PH 4.6], 25% W/V PEG MME 2000
|
Resolution 1.95 Å
R-free 0.255
|
|
2CLW
Crystal structure of human ubiquitin-conjugating enzyme UbcH5B
Deposited 2006-05-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;150 MM AMMONIUM SULPHATE, 100 MM SODIUM ACETATE TRIHYDRATE [PH 4.6], 25% W/V PEG MME 2000
|
Resolution 1.95 Å
R-free 0.255
|
|
2CLW
Crystal structure of human ubiquitin-conjugating enzyme UbcH5B
Deposited 2006-05-02
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–147(147 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;150 MM AMMONIUM SULPHATE, 100 MM SODIUM ACETATE TRIHYDRATE [PH 4.6], 25% W/V PEG MME 2000
|
Resolution 1.95 Å
R-free 0.255
|
|
2ESK
Human Ubiquitin-Conjugating Enzyme (E2) UbcH5b, wild-type
Deposited 2005-10-26
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;294 K;NaCl, PEG 6000, Sodium Acetate, temperature 294K, pH 4.5, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.36 Å
R-free 0.224
|
|
2ESO
Human Ubiquitin-Conjugating Enzyme (E2) UbcH5b mutant Ile37Ala
Deposited 2005-10-26
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Mutation:I37A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;294 K;NaCl, PEG 6000, Sodium Acetate, temperature 294K, pH 4.5, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.50 Å
R-free 0.219
|
|
2ESP
Human ubiquitin-conjugating enzyme (E2) UbcH5b mutant Ile88Ala
Deposited 2005-10-26
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Mutation:I88A
|
CL CHLORIDE ION × 1
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;294 K;NaCl, PEG 6000, Sodium Acetate, temperature 294K, pH 4.5, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.52 Å
R-free 0.233
|
|
2ESQ
Human Ubiquitin-Conjugating Enzyme (E2) UbcH5b mutant Ser94Gly
Deposited 2005-10-26
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Mutation:S94G
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.5;294 K;NaCl, PEG 6000, Sodium Acetate, temperature 294K, pH 4.5, VAPOR DIFFUSION, HANGING DROP
|
Resolution 1.44 Å
R-free 0.205
|
|
3A33
UbcH5b~Ubiquitin Conjugate
Deposited 2009-06-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–147(147 aa)
|
Mutation:C85S
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.1;293 K;2.0M NaCl, 0.1M Potassium acetate, pH 4.1, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 2.20 Å
R-free 0.280
|
|
3JVZ
E2~Ubiquitin-HECT
Deposited 2009-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
2–147(146 aa)
|
Mutation:L3S, C85S, T98K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.1;277 K;0.1 M sodium citrate, pH 5.1-5.2, 2.4-2.5 M sodium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.30 Å
R-free 0.267
|
|
3JVZ
E2~Ubiquitin-HECT
Deposited 2009-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
2–147(146 aa)
|
Mutation:L3S, C85S, T98K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.1;277 K;0.1 M sodium citrate, pH 5.1-5.2, 2.4-2.5 M sodium chloride, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.30 Å
R-free 0.267
|
|
3JW0
E2~Ubiquitin-HECT
Deposited 2009-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
2–147(146 aa)
|
Mutation:L3S, C85S, T98K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.1;277 K;0.1 M sodium citrate, 2.4M sodium chloride, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.10 Å
R-free 0.287
|
|
3JW0
E2~Ubiquitin-HECT
Deposited 2009-09-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
2–147(146 aa)
|
Mutation:L3S, C85S, T98K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.1;277 K;0.1 M sodium citrate, 2.4M sodium chloride, pH 5.1, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 3.10 Å
R-free 0.287
|
|
3L1Y
Crystal structure of human UBC4 E2 conjugating enzyme
Deposited 2009-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
Fragment:residues 1-147
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 4.6;295 K;2M sodium formate, 0.1M sodium acetate trihydrate, pH 4.6, VAPOR DIFFUSION, HANGING DROP, temperature 295K
|
Resolution 1.60 Å
R-free 0.229
|
|
3TGD
Crystal structure of the human ubiquitin-conjugating enzyme (E2) UbcH5b
Deposited 2011-08-17
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;0.8M potassium phosphate, 0.8M sodium phosphate, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 1.80 Å
R-free 0.203
|
|
3ZNI
Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex
Deposited 2013-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
2–147(146 aa)
Fragment:RESIDUES 2-147
|
Mutation:YES
|
ZN ZINC ION × 2
CA CALCIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
0.1 M BICINE, PH 9.0, 8-11% (W/V) PEG 3350 AND 0.1 M SODIUM FORMATE
|
Resolution 2.21 Å
R-free 0.211
|
|
3ZNI
Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex
Deposited 2013-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain G
2–147(146 aa)
Fragment:RESIDUES 2-147
|
Mutation:YES
|
ZN ZINC ION × 2
CA CALCIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
0.1 M BICINE, PH 9.0, 8-11% (W/V) PEG 3350 AND 0.1 M SODIUM FORMATE
|
Resolution 2.21 Å
R-free 0.211
|
|
3ZNI
Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex
Deposited 2013-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain K
2–147(146 aa)
Fragment:RESIDUES 2-147
|
Mutation:YES
|
ZN ZINC ION × 2
CA CALCIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
0.1 M BICINE, PH 9.0, 8-11% (W/V) PEG 3350 AND 0.1 M SODIUM FORMATE
|
Resolution 2.21 Å
R-free 0.211
|
|
3ZNI
Structure of phosphoTyr363-Cbl-b - UbcH5B-Ub - ZAP-70 peptide complex
Deposited 2013-02-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain O
2–147(146 aa)
Fragment:RESIDUES 2-147
|
Mutation:YES
|
ZN ZINC ION × 2
CA CALCIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
0.1 M BICINE, PH 9.0, 8-11% (W/V) PEG 3350 AND 0.1 M SODIUM FORMATE
|
Resolution 2.21 Å
R-free 0.211
|
|
4A49
Structure of phosphoTyr371-c-Cbl-UbcH5B complex
Deposited 2011-10-07
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
291 K;20% (W/V) PEG 3350 AND 0.2 M POTASSIUM THIOCYANATE AT 18 DEGREES CELSIUS.
|
Resolution 2.21 Å
R-free 0.205
|
|
4A4B
Structure of modified phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex
Deposited 2011-10-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;31-35% PENTAERYTHRITOL PROPOXYLATE (5/4 PO/OH), 0.2 M KCL, 50 MM HEPES, PH 7.5
|
Resolution 2.79 Å
R-free 0.267
|
|
4A4C
Structure of phosphoTyr371-c-Cbl-UbcH5B-ZAP-70 complex
Deposited 2011-10-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
CA CALCIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
277 K;50 MM HEPES, PH 7.5, 0.2 M KCL AND 31-35% (V/V) PENTAERYTHRITOL PROPOXYLATE (5/4 PO/OH) AT 4 DEGREES CELSIUS.
|
Resolution 2.70 Å
R-free 0.268
|
|
4AUQ
Structure of BIRC7-UbcH5b-Ub complex.
Deposited 2012-05-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–147(147 aa)
Fragment:UBCH5B, RESIDUES 1-147
Chain D
1–147(147 aa)
Fragment:UBCH5B, RESIDUES 1-147
|
Mutation:YES
Mutation:YES
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.18 Å
R-free 0.249
|
|
4DDG
Crystal structure of human OTUB1/UbcH5b~Ub/Ub
Deposited 2012-01-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain A
1–147(147 aa)
Chain B
1–147(147 aa)
Chain C
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;25% PEG1500, 0.1 M SPG, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 3.30 Å
R-free 0.280
|
|
4DDG
Crystal structure of human OTUB1/UbcH5b~Ub/Ub
Deposited 2012-01-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain J
1–147(147 aa)
Chain K
1–147(147 aa)
Chain L
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;293 K;25% PEG1500, 0.1 M SPG, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 293K
|
Resolution 3.30 Å
R-free 0.280
|
|
4DDI
Crystal structure of human OTUB1/UbcH5b~Ub/Ub
Deposited 2012-01-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 9
PDB declaration: nonameric
|
Chain A
1–147(147 aa)
Chain B
1–147(147 aa)
Chain C
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 8;293 K;25% PEG1500, 0.1 M SPG, pH 8.0, VAPOR DIFFUSION, temperature 293K
|
Resolution 3.80 Å
R-free 0.273
|
|
4LDT
The structure of h/ceOTUB1-ubiquitin aldehyde-UBCH5B~Ub
Deposited 2013-06-25
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–147(147 aa)
|
Mutation:C85S
|
EDO 1,2-ETHANEDIOL × 4
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293.15 K;1:1 mix of 12 mg/mL purified complex and well solution (100 mM Bis-Tris, pH 6.0, 200 mM magnesium chloride, 22% PEG3350), crystals appeared in about 2 to 3 days, cryoprotection with well solution + 10% ethylene glycol, flash frozen in liquid nitrogen, VAPOR DIFFUSION, HANGING DROP, temperature 293.15K
|
Resolution 1.90 Å
R-free 0.223
|
|
4V3K
RNF38-UbcH5B-UB complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
2–147(146 aa)
Fragment:RESIDUES 2-147
|
Mutation:YES
|
CL CHLORIDE ION × 3
EDO 1,2-ETHANEDIOL × 2
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
50 MM TRIS-HCL, PH 8.5 AND 2.3 M AMMONIUM SULFATE
|
Resolution 2.04 Å
R-free 0.223
|
|
4V3K
RNF38-UbcH5B-UB complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
2–147(146 aa)
Fragment:RESIDUES 2-147
|
Mutation:YES
|
CL CHLORIDE ION × 3
EDO 1,2-ETHANEDIOL × 3
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
50 MM TRIS-HCL, PH 8.5 AND 2.3 M AMMONIUM SULFATE
|
Resolution 2.04 Å
R-free 0.223
|
|
4V3L
RNF38-UB-UbcH5B-Ub complex
Deposited 2014-10-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
2–147(146 aa)
Fragment:RESIDUES 2-147
|
Mutation:YES
|
EDO 1,2-ETHANEDIOL × 2
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
50 MM HEPES, PH 7.5, 0.2 M MAGNESIUM ACETATE AND 13% (W/V) PEG 8K
|
Resolution 1.53 Å
R-free 0.193
|
|
4WZ3
Crystal structure of the complex between LubX/LegU2/Lpp2887 U-box 1 and Homo sapiens UBE2D2
Deposited 2014-11-18
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Mutation:C85S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8.5;298 K;15 mg/ml of E2D2.(C85S)-Ub conjugate and an equimolar concentration of LubX (1-186), 0.2 M sodium tartrate, 0.1 M Tris-Cl (pH 8.5) and 25% PEG3350
|
Resolution 2.70 Å
R-free 0.223
|
|
5D0K
Structure of UbE2D2:RNF165:Ub complex
Deposited 2015-08-03
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, C85K, C107S, C111S
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;MES, sodium chloride, PEG 6000
|
Resolution 2.65 Å
R-free 0.238
|
|
5D0K
Structure of UbE2D2:RNF165:Ub complex
Deposited 2015-08-03
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–147(147 aa)
|
Mutation:C21S, C85K, C107S, C111S
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;MES, sodium chloride, PEG 6000
|
Resolution 2.65 Å
R-free 0.238
|
|
5D0K
Structure of UbE2D2:RNF165:Ub complex
Deposited 2015-08-03
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
1–147(147 aa)
|
Mutation:C21S, C85K, C107S, C111S
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;MES, sodium chloride, PEG 6000
|
Resolution 2.65 Å
R-free 0.238
|
|
5D0K
Structure of UbE2D2:RNF165:Ub complex
Deposited 2015-08-03
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain J
1–147(147 aa)
|
Mutation:C21S, C85K, C107S, C111S
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;MES, sodium chloride, PEG 6000
|
Resolution 2.65 Å
R-free 0.238
|
|
5D0M
Structure of UbE2D2:RNF165:Ub complex
Deposited 2015-08-03
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, S22R, C85K, C107S, C111S
|
PO4 PHOSPHATE ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291.15 K;SPG buffer, PEG 1500
|
Resolution 1.91 Å
R-free 0.213
|
|
5D1K
Crystal Structure of UbcH5B in Complex with the RING-U5BR Fragment of AO7
Deposited 2015-08-04
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 3
PEG DI(HYDROXYETHYL)ETHER × 1
OXL OXALATE ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;292 K;20% PEG-10000, 8% ethylene glycol, 0.1M HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 1.78 Å
R-free 0.202
|
|
5D1L
Crystal Structure of UbcH5B in Complex with the RING-U5BR Fragment of AO7 (Y165A)
Deposited 2015-08-04
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 1
OXL OXALATE ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;292 K;15% PEG 20000, 0.1M MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 1.62 Å
R-free 0.200
|
|
5D1M
Crystal Structure of UbcH5B in Complex with the RING-U5BR Fragment of AO7 (P199A)
Deposited 2015-08-04
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
OXL OXALATE ION × 1
PEG DI(HYDROXYETHYL)ETHER × 1
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;292 K;20% PEG 10000, 8% Ethylene glycol, 0.1M HEPS, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 292K
|
Resolution 1.58 Å
R-free 0.223
|
|
5EDV
Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex
Deposited 2015-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
2–147(146 aa)
|
Mutation:S22R, C85K
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-
Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
|
Resolution 3.48 Å
R-free 0.303
|
|
5EDV
Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex
Deposited 2015-10-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain C
2–147(146 aa)
Chain D
2–147(146 aa)
|
Mutation:S22R, C85K
Mutation:S22R, C85K
|
ZN ZINC ION × 16
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-
Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
|
Resolution 3.48 Å
R-free 0.303
|
|
5EDV
Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex
Deposited 2015-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain D
2–147(146 aa)
|
Mutation:S22R, C85K
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-
Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
|
Resolution 3.48 Å
R-free 0.303
|
|
5EDV
Structure of the HOIP-RBR/UbcH5B~ubiquitin transfer complex
Deposited 2015-10-22
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain I
2–147(146 aa)
|
Mutation:S22R, C85K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8.5;285 K;0.06M Tris, 0.04M Bicine, 0.02 M 1,6-Hexanediol, 0.02 M 1-Butanol, 0.02 M 1,2-
Propanediol (racemic), 0.02 M 2-Propanol, 0.02 M 1,4-Butanediol, 0.02 M 1,3-Propanediol, 20% PEG550MME, 10% PEG20K, 8% glycerol
|
Resolution 3.48 Å
R-free 0.303
|
|
5MNJ
Structure of MDM2-MDMX-UbcH5B-ubiquitin complex
Deposited 2016-12-13
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–147(147 aa)
|
Mutation:S22R, C85K
|
ZN ZINC ION × 4
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;292 K;0.1 M Tris-HCl, pH 8.5, 0.175 M Li2SO4 and 16-20 %(v/v) PEG 3350
|
Resolution 2.16 Å
R-free 0.231
|
|
5MNJ
Structure of MDM2-MDMX-UbcH5B-ubiquitin complex
Deposited 2016-12-13
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain E
1–147(147 aa)
|
Mutation:S22R, C85K
|
ZN ZINC ION × 4
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;292 K;0.1 M Tris-HCl, pH 8.5, 0.175 M Li2SO4 and 16-20 %(v/v) PEG 3350
|
Resolution 2.16 Å
R-free 0.231
|
|
5ULF
Crystal Structure of a UbcH5b~Ub conjugate
Deposited 2017-01-24
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, S22R, C85K, C107S, C111S
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;100 mM bis-Tris pH 5.5, 150 mM ammonium sulfate, 20% PEG 3350
|
Resolution 1.80 Å
R-free 0.261
|
|
5ULF
Crystal Structure of a UbcH5b~Ub conjugate
Deposited 2017-01-24
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–147(147 aa)
|
Mutation:C21S, S22R, C85K, C107S, C111S
|
GOL GLYCEROL × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.5;289 K;100 mM bis-Tris pH 5.5, 150 mM ammonium sulfate, 20% PEG 3350
|
Resolution 1.80 Å
R-free 0.261
|
|
5ULH
Structure of RNF165 in complex with a UbcH5b~Ub conjugate
Deposited 2017-01-24
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, C85K, C107S, C111S
|
GOL GLYCEROL × 2
SCN THIOCYANATE ION × 2
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289 K;200 mM potassium thiocyanate, 20% PEG 3350
|
Resolution 1.95 Å
R-free 0.217
|
|
5ULK
Crystal Structure of RNF165 in complex with a UbcH5b~Ub conjugate
Deposited 2017-01-24
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, C85K, C107S, C111S
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289 K;200 mM ammonium nitrate, 20% PEG 3350
|
Resolution 2.38 Å
R-free 0.267
|
|
5VZW
TRIM23 RING domain in complex with UbcH5-Ub
Deposited 2017-05-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
1–147(147 aa)
Chain B
1–147(147 aa)
|
Mutation:S22R,C85K
Mutation:S22R,C85K
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;0.1 M Bis-Tris, pH 5.5, 0.2 M calcium chloride, 17% w/v PEG3350
|
Resolution 2.28 Å
R-free 0.237
|
|
5ZBU
Crystal Structure of PA-TM-RING E3 ligase RNF13 RING domain in complex with E2~Ub
Deposited 2018-02-12
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–147(147 aa)
|
Mutation:C85K
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.1M MES monohydrate, 14% PEG 4000
|
Resolution 3.20 Å
R-free 0.262
|
|
5ZBU
Crystal Structure of PA-TM-RING E3 ligase RNF13 RING domain in complex with E2~Ub
Deposited 2018-02-12
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
1–147(147 aa)
|
Mutation:C85K
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;293 K;0.1M MES monohydrate, 14% PEG 4000
|
Resolution 3.20 Å
R-free 0.262
|
|
6HPR
Crystal structure of cIAP1 RING domain bound to UbcH5B-Ub and a non-covalent Ub
Deposited 2018-09-21
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain C
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;292 K;0.2 M ammonium fluoride and 15% (w/v) PEG 3350
|
Resolution 1.70 Å
R-free 0.197
|
|
6M2C
Distinct mechanism of MUL1-RING domain simultaneously recruiting E2 enzyme and the substrate p53-TAD domain
Deposited 2020-02-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;4% v/v Tacsimate pH 6.0, 12% w/v Polyethylene glycol 3350
|
Resolution 2.70 Å
R-free 0.258
|
|
6M2C
Distinct mechanism of MUL1-RING domain simultaneously recruiting E2 enzyme and the substrate p53-TAD domain
Deposited 2020-02-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;4% v/v Tacsimate pH 6.0, 12% w/v Polyethylene glycol 3350
|
Resolution 2.70 Å
R-free 0.258
|
|
6M2C
Distinct mechanism of MUL1-RING domain simultaneously recruiting E2 enzyme and the substrate p53-TAD domain
Deposited 2020-02-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;4% v/v Tacsimate pH 6.0, 12% w/v Polyethylene glycol 3350
|
Resolution 2.70 Å
R-free 0.258
|
|
6M2C
Distinct mechanism of MUL1-RING domain simultaneously recruiting E2 enzyme and the substrate p53-TAD domain
Deposited 2020-02-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;4% v/v Tacsimate pH 6.0, 12% w/v Polyethylene glycol 3350
|
Resolution 2.70 Å
R-free 0.258
|
|
6SQO
Crystal structure of human MDM2 RING domain homodimer bound to UbcH5B-Ub
Deposited 2019-09-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
2–147(146 aa)
Chain E
2–147(146 aa)
|
Mutation:S22R, C85K
Mutation:S22R, C85K
|
ZN ZINC ION × 4
CL CHLORIDE ION × 4
NO3 NITRATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;292 K;0.1 M SPG, pH 7.0, 10% (w/v) PEG Smear Broad, 0.15 M NH4NO3
|
Resolution 1.41 Å
R-free 0.173
|
|
6SQR
Crystal structure of Cat MDM2-S429E RING domain bound to UbcH5B-Ub
Deposited 2019-09-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
2–147(146 aa)
Chain E
2–147(146 aa)
Chain H
2–147(146 aa)
Chain K
2–147(146 aa)
|
Mutation:S22R, C85K
Mutation:S22R, C85K
Mutation:S22R, C85K
Mutation:S22R, C85K
|
EDO 1,2-ETHANEDIOL × 12
ZN ZINC ION × 8
NO3 NITRATE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;292 K;0.1 M Tris-HCl, pH 8.5, 20% (v/v) PEG Smear High
|
Resolution 2.18 Å
R-free 0.227
|
|
6SQS
Crystal structure of cat phospho-Ser429 MDM2 RING domain bound to UbcH5B-Ub
Deposited 2019-09-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain B
2–147(146 aa)
Chain E
2–147(146 aa)
|
Mutation:S22R, C85K
Mutation:S22R, C85K
|
ZN ZINC ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;292 K;0.1 M Tris-HCl, pH 8.0, 15% (w/v) PEG 2000 MME and 0.1 M KCl
|
Resolution 1.83 Å
R-free 0.242
|
|
6TTU
Ubiquitin Ligation to substrate by a cullin-RING E3 ligase at 3.7A resolution: NEDD8-CUL1-RBX1 N98R-SKP1-monomeric b-TRCP1dD-IkBa-UB~UBE2D2
Deposited 2019-12-30
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 8
PDB declaration: octameric
|
Chain D
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.8
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 3.70 Å
|
|
6W7Z
RNF12 RING domain in complex with Ube2d2
Deposited 2020-03-19
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
GOL GLYCEROL × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289 K;15-20% PEG 3350, 100-200 mM ammonium formate
|
Resolution 1.80 Å
R-free 0.211
|
|
6W9D
RNF12 RING domain in complex with a Ube2d2~Ub conjugate
Deposited 2020-03-22
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, S22R, C85K, C107S, C111S
|
ZN ZINC ION × 2
IOD IODIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;15-20% PEG 3350,
200-400 mM NaI
|
Resolution 3.19 Å
R-free 0.281
|
|
6W9D
RNF12 RING domain in complex with a Ube2d2~Ub conjugate
Deposited 2020-03-22
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–147(147 aa)
|
Mutation:C21S, S22R, C85K, C107S, C111S
|
ZN ZINC ION × 2
IOD IODIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;15-20% PEG 3350,
200-400 mM NaI
|
Resolution 3.19 Å
R-free 0.281
|
|
6W9D
RNF12 RING domain in complex with a Ube2d2~Ub conjugate
Deposited 2020-03-22
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain G
1–147(147 aa)
|
Mutation:C21S, S22R, C85K, C107S, C111S
|
ZN ZINC ION × 2
IOD IODIDE ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;289 K;15-20% PEG 3350,
200-400 mM NaI
|
Resolution 3.19 Å
R-free 0.281
|
|
7AI0
Crystal structure of human MDM2-G443T RING domain homodimer bound to UbcH5B-Ub (Crystal form 1)
Deposited 2020-09-25
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain BBB
1–147(147 aa)
|
Mutation:S22R, C85K
|
CL CHLORIDE ION × 4
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris, 0.075 M NaOAc, 0.1 M NaCl, 15 % w/v PEG Smear Medium
|
Resolution 1.56 Å
R-free 0.185
|
|
7AI0
Crystal structure of human MDM2-G443T RING domain homodimer bound to UbcH5B-Ub (Crystal form 1)
Deposited 2020-09-25
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain EEE
1–147(147 aa)
|
Mutation:S22R, C85K
|
CL CHLORIDE ION × 1
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;292 K;0.1 M Tris, 0.075 M NaOAc, 0.1 M NaCl, 15 % w/v PEG Smear Medium
|
Resolution 1.56 Å
R-free 0.185
|
|
7AI1
Crystal structure of human MDM2-G443T RING domain homodimer bound to UbcH5B-Ub (Crystal form 2)
Deposited 2020-09-25
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain BBB
1–147(147 aa)
|
Mutation:S22R, C85K
|
CL CHLORIDE ION × 1
ZN ZINC ION × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;292 K;0.1 M HEPES, 0.2 M NH4NO3, 20 % w/v PEG Smear Broad
|
Resolution 2.07 Å
R-free 0.266
|
|
7AI1
Crystal structure of human MDM2-G443T RING domain homodimer bound to UbcH5B-Ub (Crystal form 2)
Deposited 2020-09-25
|
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain EEE
1–147(147 aa)
|
Mutation:S22R, C85K
|
CL CHLORIDE ION × 1
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;292 K;0.1 M HEPES, 0.2 M NH4NO3, 20 % w/v PEG Smear Broad
|
Resolution 2.07 Å
R-free 0.266
|
|
7BOL
ubiquitin-conjugating enzyme, Ube2D2
Deposited 2020-03-19
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.5 M Ammonium sulfate
0.1 M Sodium citrate pH 5.6
1.0 M Lithium sulfate
|
Resolution 1.80 Å
R-free 0.219
|
|
7R71
Crystal Structure of the UbArk2C-UbcH5b~Ub complex
Deposited 2021-06-24
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain C
1–147(147 aa)
|
Mutation:C21S, S22R, C85K, C107S, C111S
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;289.15 K;0.1 M MMT pH 6.0, 25% w/v PEG 1500
|
Resolution 2.80 Å
R-free 0.271
|
|
8B3I
CRL4CSA-E2-Ub (state 2)
Deposited 2022-09-16
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain D
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
8GBQ
Structure of RNF125 in complex with UbcH5b
Deposited 2023-02-27
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
GOL GLYCEROL × 1
ZN ZINC ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 9.5;289 K;0.1 M CHES 9.5
20% PEG 8000
|
Resolution 1.74 Å
R-free 0.201
|
|
8GCB
Structure of RNF125 in complex with a UbcH5b~Ub conjugate
Deposited 2023-03-01
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH;pH 9;289 K;0.1 M BICINE pH 9.0, 20% PEG 6000
|
Resolution 2.39 Å
R-free 0.271
|
|
8JWU
PHD Finger Protein 7 (PHF7) fused to UBE2D2 via a (GSGG)3 linker
Deposited 2023-06-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–147(147 aa)
|
Mutation:S346R,C409K
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;PEG8000, DMSO, MOPS
|
Resolution 3.58 Å
R-free 0.265
|
|
8JWU
PHD Finger Protein 7 (PHF7) fused to UBE2D2 via a (GSGG)3 linker
Deposited 2023-06-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–147(147 aa)
|
Mutation:S346R,C409K
|
ZN ZINC ION × 7
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;PEG8000, DMSO, MOPS
|
Resolution 3.58 Å
R-free 0.265
|
|
8JWU
PHD Finger Protein 7 (PHF7) fused to UBE2D2 via a (GSGG)3 linker
Deposited 2023-06-29
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–147(147 aa)
|
Mutation:S346R,C409K
|
ZN ZINC ION × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;277 K;PEG8000, DMSO, MOPS
|
Resolution 3.58 Å
R-free 0.265
|
|
8V0D
Ubch5B-RING3 of MIB1 fusion structure
Deposited 2023-11-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
Chain B
1–147(147 aa)
|
Not recorded
|
ZN ZINC ION × 5
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6;291 K;4% v/v TacsimateTM pH 6.0,
12% w/v Polyethylene glycol 3,350
|
Resolution 2.40 Å
R-free 0.243
|
|
8VK8
Structure of UbV.d2.1 in complex with Ube2d2
Deposited 2024-01-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, C107S, and C111S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;289 K;0.1 M Sodium citrate pH 5.6,
20% w/v PEG 4000,
20% v/v 2-Propanol
|
Resolution 2.99 Å
R-free 0.295
|
|
8VK8
Structure of UbV.d2.1 in complex with Ube2d2
Deposited 2024-01-08
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain D
1–147(147 aa)
|
Mutation:C21S, C107S, and C111S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;289 K;0.1 M Sodium citrate pH 5.6,
20% w/v PEG 4000,
20% v/v 2-Propanol
|
Resolution 2.99 Å
R-free 0.295
|
|
8VK8
Structure of UbV.d2.1 in complex with Ube2d2
Deposited 2024-01-08
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
1–147(147 aa)
|
Mutation:C21S, C107S, and C111S
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.6;289 K;0.1 M Sodium citrate pH 5.6,
20% w/v PEG 4000,
20% v/v 2-Propanol
|
Resolution 2.99 Å
R-free 0.295
|
|
8VK9
Structure of UbV.d2.3 in complex with Ube2d2-S22R
Deposited 2024-01-08
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Mutation:C21S, S22R, C107S, C111S
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;0.1 M Sodium HEPES pH 7.0,
15% w/v PEG 20,000
|
Resolution 2.00 Å
R-free 0.224
|
|
8VK9
Structure of UbV.d2.3 in complex with Ube2d2-S22R
Deposited 2024-01-08
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–147(147 aa)
|
Mutation:C21S, S22R, C107S, C111S
|
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;0.1 M Sodium HEPES pH 7.0,
15% w/v PEG 20,000
|
Resolution 2.00 Å
R-free 0.224
|
|
8VK9
Structure of UbV.d2.3 in complex with Ube2d2-S22R
Deposited 2024-01-08
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
1–147(147 aa)
|
Mutation:C21S, S22R, C107S, C111S
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;0.1 M Sodium HEPES pH 7.0,
15% w/v PEG 20,000
|
Resolution 2.00 Å
R-free 0.224
|
|
8VK9
Structure of UbV.d2.3 in complex with Ube2d2-S22R
Deposited 2024-01-08
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
1–147(147 aa)
|
Mutation:C21S, S22R, C107S, C111S
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;289 K;0.1 M Sodium HEPES pH 7.0,
15% w/v PEG 20,000
|
Resolution 2.00 Å
R-free 0.224
|
|
9DNS
Cryo-EM structure of Tom1-UBE2D2-ubiquitin complex
Deposited 2024-09-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 7
PDB declaration: heptameric
|
Chain D
1–147(147 aa)
Chain E
1–147(147 aa)
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.2;30 mM HEPES pH 7.2, 200 mM NaCl, 0.5 mM TCEP, 0.2 mM CHAPSO
cryo-EM vitrification conditions
Cryogen ETHANE;CHAPSO detergent added to final conc. of 0.2 mM. Sample applied twice.
|
Resolution 2.80 Å
|
|
9GLS
Crystal Structure of Human UBCH5B C85E
Deposited 2024-08-28
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain AAA
1–147(147 aa)
|
Mutation:C85E
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 9;293 K;10% PEG 200, 0.1 M Bis-Tris propane, pH 9, 15% PEG 8000
|
Resolution 1.25 Å
R-free 0.211
|
|
9Q8Y
Structure of RNF38 RING with linchpin mutant R454Y in complex with Ubch5B-Ub
Deposited 2025-02-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
2–147(146 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.6;293 K;0.2 M Sodium acetate trihydrate, 0.1 M Imidazole pH 8.0, 10% PEG 8000
|
Resolution 2.63 Å
R-free 0.275
|
|
9Q8Y
Structure of RNF38 RING with linchpin mutant R454Y in complex with Ubch5B-Ub
Deposited 2025-02-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain B
2–147(146 aa)
|
Not recorded
|
ZN ZINC ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.6;293 K;0.2 M Sodium acetate trihydrate, 0.1 M Imidazole pH 8.0, 10% PEG 8000
|
Resolution 2.63 Å
R-free 0.275
|
|
9YE9
Structure of UbcH5b in complex with the U-box domain of the E3 ubiquitin ligase CHIP
Deposited 2025-09-23
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 3
PDB declaration: trimeric
|
Chain A
1–147(147 aa)
|
Mutation:M1K, C85K
|
BME BETA-MERCAPTOETHANOL × 5
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7;298 K;0.1 M Magnesium chloride hexahydrate, 0.1 M Potassium chloride, 0.1 M PIPES, 20 % v/v PEG Smear Medium
|
Resolution 2.01 Å
R-free 0.288
|
|
9YEA
Structure of the isopeptide bond-linked UbcH5b~Ubiquitin conjugate complex for an M1K/C85K UbcH5b mutant
Deposited 2025-09-23
|
Different mutation/modification
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–147(147 aa)
|
Mutation:M1K, C85K
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 5.5;298 K;0.1 M Sodium Citrate, 20 % (w/v) PEG 3000
|
Resolution 1.83 Å
R-free 0.239
|